Publications

SHLD1 is dispensable for 53BP1-dependent V(D)J recombination but critical for productive class switch recombination.

Authors: E Vincendeau, W Wei, X Zhang, C Planchais, W Yu, H Lenden-Hasse, T Cokelaer...

Research group: Jackson Group

E-pub date: 28 Jun 2022

Journal name: Nat Commun

Abstract 53: The copy number landscape of early stage ovarian high grade serous carcinoma

Authors: Z Cheng, HB Mirza, DP Ennis, P Smith, LM Gavarró, C Sokota, G Giannone, T ...

Research group: Markowetz Group, Brenton Group

E-pub date: 15 Jun 2022

Journal name: Cancer Research

Abstract 476: Predicting response to treatment in early breast cancer using dynamic integrative multi-omic profiling

Authors: S-J Sammut, M Crispin-Ortuzar, S-F Chin, E Provenzano, W Cope, A Dariush, S...

Research group: Markowetz Group

E-pub date: 15 Jun 2022

Journal name: Cancer Research

Tracing back to one of the origins of immune evasion in pancreatic cancer.

Authors: J Araos Henríquez, G Biffi

Research group: Biffi Group

E-pub date: 13 Jun 2022

Journal name: Cancer Cell

Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma.

Authors: CA Rebbeck, J Xian, S Bornelöv, J Geradts, A Hobeika, H Geiger, JF Alvarez...

Research group: Hannon Group

E-pub date: 13 Jun 2022

Journal name: Nat Commun

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.

Authors: RC Coombes, PD Badman, JP Lozano-Kuehne, X Liu, IR Macpherson, I Zubairi, R...

Research group:

E-pub date: 10 Jun 2022

Journal name: Nat Commun

Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant.

Authors: L Correia, R Magno, JM Xavier, BP de Almeida, I Duarte, F Esteves, M Ghezzo...

Research group: Bioinformatics

E-pub date: 8 Jun 2022

Journal name: NPJ Breast Cancer

PATH-04. Array-based global DNA Methylation profiling of mouse brain tumors allows comparison to human tumors

Authors: M Schoof, M Spohn, M Dorostkar, S Neyazi, M Bockmayr, F Swartling, D Kawauc...

Research group: Gilbertson Group

E-pub date: 3 Jun 2022

Journal name: Neuro-Oncology

Filters

Research Groups

Core Facilities

Start date

End date

SHLD1 is dispensable for 53BP1-dependent V(D)J recombination but critical for productive class switch recombination.

Abstract 53: The copy number landscape of early stage ovarian high grade serous carcinoma

Abstract 476: Predicting response to treatment in early breast cancer using dynamic integrative multi-omic profiling

Tracing back to one of the origins of immune evasion in pancreatic cancer.

Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma.

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.

Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant.

PATH-04. Array-based global DNA Methylation profiling of mouse brain tumors allows comparison to human tumors

Themes

Filters

Research Groups

Core Facilities

Start date

End date

SHLD1 is dispensable for 53BP1-dependent V(D)J recombination but critical for productive class switch recombination.

Abstract 53: The copy number landscape of early stage ovarian high grade serous carcinoma

Abstract 476: Predicting response to treatment in early breast cancer using dynamic integrative multi-omic profiling

Tracing back to one of the origins of immune evasion in pancreatic cancer.

Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma.

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.

Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant.

PATH-04. Array-based global DNA Methylation profiling of mouse brain tumors allows comparison to human tumors